These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22048694)

  • 1. Biochemical and biophysical characterization of humanized IgG1 produced in Pichia pastoris.
    Ha S; Wang Y; Rustandi RR
    MAbs; 2011; 3(5):453-60. PubMed ID: 22048694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of DC-SIGN to glycoproteins expressed in glycoengineered Pichia pastoris.
    Cukan MC; Hopkins D; Burnina I; Button M; Giaccone E; Houston-Cummings NR; Jiang Y; Li F; Mallem M; Mitchell T; Moore R; Nylen A; Prinz B; Rios S; Sharkey N; Zha D; Hamilton S; Li H; Stadheim TA
    J Immunol Methods; 2012 Dec; 386(1-2):34-42. PubMed ID: 22982058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of humanized IgGs in glycoengineered Pichia pastoris.
    Li H; Sethuraman N; Stadheim TA; Zha D; Prinz B; Ballew N; Bobrowicz P; Choi BK; Cook WJ; Cukan M; Houston-Cummings NR; Davidson R; Gong B; Hamilton SR; Hoopes JP; Jiang Y; Kim N; Mansfield R; Nett JH; Rios S; Strawbridge R; Wildt S; Gerngross TU
    Nat Biotechnol; 2006 Feb; 24(2):210-5. PubMed ID: 16429149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosylation characterization of recombinant human erythropoietin produced in glycoengineered Pichia pastoris by mass spectrometry.
    Gong B; Burnina I; Stadheim TA; Li H
    J Mass Spectrom; 2013 Dec; 48(12):1308-17. PubMed ID: 24338886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering aggregation resistance in IgG by two independent mechanisms: lessons from comparison of Pichia pastoris and mammalian cell expression.
    Schaefer JV; Plückthun A
    J Mol Biol; 2012 Apr; 417(4):309-35. PubMed ID: 22306407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of a glycoengineered Pichia pastoris cultivation process for commercial antibody production.
    Ye J; Ly J; Watts K; Hsu A; Walker A; McLaughlin K; Berdichevsky M; Prinz B; Sean Kersey D; d'Anjou M; Pollard D; Potgieter T
    Biotechnol Prog; 2011; 27(6):1744-50. PubMed ID: 22002933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of sialylated O-linked glycans in Pichia pastoris.
    Hamilton SR; Cook WJ; Gomathinayagam S; Burnina I; Bukowski J; Hopkins D; Schwartz S; Du M; Sharkey NJ; Bobrowicz P; Wildt S; Li H; Stadheim TA; Nett JH
    Glycobiology; 2013 Oct; 23(10):1192-203. PubMed ID: 23893788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo anti-tumor efficacy of afucosylated anti-CS1 monoclonal antibody produced in glycoengineered Pichia pastoris.
    Gomathinayagam S; Laface D; Houston-Cummings NR; Mangadu R; Moore R; Shandil I; Sharkey N; Li H; Stadheim TA; Zha D
    J Biotechnol; 2015 Aug; 208():13-21. PubMed ID: 26015261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-scale metabolic model of Pichia pastoris with native and humanized glycosylation of recombinant proteins.
    Irani ZA; Kerkhoven EJ; Shojaosadati SA; Nielsen J
    Biotechnol Bioeng; 2016 May; 113(5):961-9. PubMed ID: 26480251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of IgG1 monoclonal antibodies produced in humanized Pichia pastoris with specific glycoforms: a comparative study with CHO produced materials.
    Liu L; Stadheim A; Hamuro L; Pittman T; Wang W; Zha D; Hochman J; Prueksaritanont T
    Biologicals; 2011 Jul; 39(4):205-10. PubMed ID: 21723741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human lactoferrin expressed in glycoengineered Pichia pastoris: effect of terminal N-acetylneuraminic acid on in vitro secondary humoral immune response.
    Choi BK; Actor JK; Rios S; d'Anjou M; Stadheim TA; Warburton S; Giaccone E; Cukan M; Li H; Kull A; Sharkey N; Gollnick P; Kocieba M; Artym J; Zimecki M; Kruzel ML; Wildt S
    Glycoconj J; 2008 Aug; 25(6):581-93. PubMed ID: 18365311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of monoclonal antibodies by glycoengineered Pichia pastoris.
    Potgieter TI; Cukan M; Drummond JE; Houston-Cummings NR; Jiang Y; Li F; Lynaugh H; Mallem M; McKelvey TW; Mitchell T; Nylen A; Rittenhour A; Stadheim TA; Zha D; d'Anjou M
    J Biotechnol; 2009 Feb; 139(4):318-25. PubMed ID: 19162096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substitution of Pichia pastoris-derived recombinant proteins with mannose containing O- and N-linked glycans decreases specificity of diagnostic tests.
    van Oort E; Lerouge P; de Heer PG; Séveno M; Coquet L; Modderman PW; Faye L; Aalberse RC; van Ree R
    Int Arch Allergy Immunol; 2004 Nov; 135(3):187-95. PubMed ID: 15467371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of Full-Length Antibody by Pichia pastoris.
    Nylen A; Chen MT
    Methods Mol Biol; 2018; 1674():37-48. PubMed ID: 28921426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of N-glycan site occupancy of therapeutic glycoproteins produced in Pichia pastoris.
    Choi BK; Warburton S; Lin H; Patel R; Boldogh I; Meehl M; d'Anjou M; Pon L; Stadheim TA; Sethuraman N
    Appl Microbiol Biotechnol; 2012 Aug; 95(3):671-82. PubMed ID: 22569635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of N-linked glycosylation on recombinant glycoproteins produced in Pichia pastoris using ESI-MS and MALDI-TOF.
    Gong B; Cukan M; Fisher R; Li H; Stadheim TA; Gerngross T
    Methods Mol Biol; 2009; 534():213-23. PubMed ID: 19277549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homogeneous production and characterization of recombinant N-GlcNAc-protein in Pichia pastoris.
    Wang S; Rong Y; Wang Y; Kong D; Wang PG; Chen M; Kong Y
    Microb Cell Fact; 2020 Jan; 19(1):7. PubMed ID: 31931833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A practical approach for O-linked mannose removal: the use of recombinant lysosomal mannosidase.
    Hopkins D; Gomathinayagam S; Hamilton SR
    Appl Microbiol Biotechnol; 2015 May; 99(9):3913-27. PubMed ID: 25381909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining expression and process engineering for high-quality production of human sialyltransferase in Pichia pastoris.
    Luley-Goedl C; Czabany T; Longus K; Schmölzer K; Zitzenbacher S; Ribitsch D; Schwab H; Nidetzky B
    J Biotechnol; 2016 Oct; 235():54-60. PubMed ID: 27018228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering the Pichia pastoris N-Glycosylation Pathway Using the GlycoSwitch Technology.
    Laukens B; De Wachter C; Callewaert N
    Methods Mol Biol; 2015; 1321():103-22. PubMed ID: 26082218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.